Patient Population definition

Patient Population means the Heterozygous Population or the Homozygous Population.

Split View

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Get StartedSchedule a Demo

Patient Population means, with respect to any Licensed Product, the targeted patient population as defined in (i) the respective draft or approved study protocol for a Phase II Clinical Trial or Phase III Clinical Trial or (ii) the respective draft or approved product label (as approved by the competent Regularory Authority).

Patient Population means the specific group of patients (by histologic or genetic subtype or line of therapy) suffering from an Indication. Such group in the context of Clinical Trials is the specific group of patients that could possibly serve as the population for studying the effects of a Licensed Product(s) targeting the Indication during a Clinical Trial. For the sake of clarity, treatment of different subpopulations within an Indication will be deemed separate Patient Populations for purposes of this Agreement (e.g., front-line treatment, relapsed refractory treatment and maintenance treatment of a given Indication will be considered different Patient Populations and [***] and biomarker-positive [***] will be considered different Patient Populations).

Examples of Patient Population in a sentence

• The IRO then shall select a random sample of 25 Rehab Therapy Patients from the Rehab Therapy Patient Population for each randomly-selected Service Location.

• The royalty rate payable with respect to each Product sold by Akcea or its Affiliates will be based on whether the Product gains Approval for, and Akcea sells such Product for, the treatment of a Rare Disease Indication or a Broad Patient Population Indication.

• For the United States and Europe, on a region-by-region basis, the Rare Disease Indication royalty rate will apply to Akcea’s Net Sales of a Product in the applicable region until Akcea gains Approval, and makes a First Commercial Sale, for the treatment of a Broad Patient Population Indication of such Product in such region.

• For all other countries that are not in the United States or Europe, the Rare Disease Indication royalty rate will apply to Akcea’s Net Sales of a Product in such country until such Product achieves Approval in both the United States and Europe for a Broad Patient Population Indication (in which case the Broad Patient Population Indication royalty rate will apply to all Net Sales related to such Product).

• The Parties’ will designate which diseases will be included in each of the Rare Disease Indication and Broad Patient Population Indication category for each Product in the Strategic Plan.

• Study Design [**] Dosing Arms [**] Patient Population [**] Endpoints [**] Estimated Enrollment [**] Objective To evaluate the [**].

• In the event that OIG exercises its discretion to limit the Rehab Therapy Patient Population or the Service Location Population, OIG shall notify RehabCare at least 60 days prior to the end of the Reporting Period of any information needed from RehabCare in order for the OIG to identify the Rehab Therapy Patient Population (e.g., RUG level, length of stay, etc.) or the Service Location Population (e.g., revenue, patient volume information, etc.).

• A description of the Service Location Population and the Rehab Therapy Patient Population subject to the Rehab Medical Review.

• The Rehab Therapy Patient Population shall be defined as all Rehab Therapy Patients at a randomly selected Service Location during the 12-month period covered by the Rehab Medical Review.

• ISIS- APOCIIIRx ISIS-APOCIII-LRx (LICA) ISIS- APO(a)-LRx (LICA) ISIS-ANGPTL3-LRx (LICA) Rare Disease Indication 25 % 20 % 20 % 20 % Broad Patient Population Indication 25 % 15 % 15 % 15 % Akcea will pay Isis royalties on Net Sales of Products sold by Akcea or its Affiliates arising from named patient and other similar programs under Applicable Laws, and Akcea will provide reports and payments to Isis consistent with this ARTICLE 6.

More Definitions of Patient Population

Patient Population. Male and female patients with severe heterogeneous emphysema meeting the study eligibility criteria.

Patient Population means the number of patients whose data/records are included within the Data to be made available through the Data Access under the relevant Order Form. In the case of Third Party Data, this will include all Third Party Data at each relevant Site. Patient Population Bundle means an additional subscription for the Solution(s) and Services purchased by the Customer during an Order Form Term in accordance with paragraph 4 of this Schedule 4. Population Customer means all customers which are not a Community Customer, Explorer Insights Customer or Hospice Customer. Renewal Subscription means renewal of an Initial Subscription or previous Renewal Subscription purchased by the Customer at the start of any Renewal Order Form Term, in accordance with paragraph 3 of this Schedule 4. Site means each site operated by a Third Party Data Controller that the Customer has requested EMIS to enable a data sharing agreement in accordance with clause 17.5 (whether such agreements are activated by the relevant Third Party Data Controllers or not). A single Third Party Data Controller may operate more than one Site, each of which shall count as a single Site under the terms of the Agreement. Subscription means, as applicable, an Initial Subscription, Renewal Subscription, Patient Population Bundle and/or a Top Up related to the relevant Order Form.

Patient Population the number of persons registered as patients “Set-up Fee” any fee payable in relation to the installation and set-up of the Software and or any Localisation Plan as set out at Schedule 1. "Site" the premises from which the Customer carries out its business as stated above or as notified to the Supplier in writing from time to time.